<h4>Objectives</h4>Research focused on clinical differences and long-term prognosis in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis (anti-MDA5+ DM) patients across age groups remains limited. This evidence concerns the gene IFIH1 and dermatomyositis.